
Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4+ T cells
Author(s) -
Nadejda Beliakova-Bethell,
Jin X. Zhang,
Akul Singhania,
Vivian Lee,
Valeri H. Terry,
Douglas D. Richman,
Celsa A. Spina,
Christopher H. Woelk
Publication year - 2013
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32835b3e26
Subject(s) - biology , gene expression , histone deacetylase inhibitor , transcriptome , vorinostat , biological pathway , microarray analysis techniques , histone deacetylase , gene knockdown , histone , microbiology and biotechnology , regulation of gene expression , gene expression profiling , gene , cancer research , genetics
To assess the off-target effects of the histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA) in human primary CD4 T cells.